Title of Invention

ENHANCED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS

Abstract

A personal care composition is provided having a fragrance which incorporates limonene, gamma terpinene, ethylene brassylate or combinations thereof in conjunction with a quaternary ammonium salt. The salt has a structure AB, wherein A is a cationic charge component, B is an anionic charge component, and A has one quaternized nitrogen atom, at least two hydroxyl groups and a molecular weight no higher than 250. The quaternary ammonium salt functions as a scent boosting agent to enhance volatilization of the fragrance components when the personal care composition is first applied to skin or hair of the human body.

Full Text

FORM - 2 THE PATENTS ACT, 1970 (39 of 1970) & The Patents Rules, 2003 COMPLETE SPECIFICATION (See Section 10 and Rule 13) ENCHANCED DELIVERY OF CERTAIN FRAGARNCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India The following specification particularly describes the invention and the manner in which it is to be performed ENHANCED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS BACKGROUND OF THE INVENTION The invention concerns personal care compositions which upon application to a human body surface quickly release certain fragrance components thereby improving aesthetics of these compositions. Perhaps the most significant aesthetic of a personal care product for a consumer is fragrance. It is also important to rapidly deliver the scent. Many techniques have been reported to manipulate timing and impact of fragrance. Delayed generation has been achieved through encapsulation of scent ingredients. For instance, U.S. Patent 5,135,747 (Faryniarz et al.) reports an unscented malodor counteractant deo perfume mixture encapsulated within a semi-permeable wall material and a quicker releasable non-encapsulated fragrance perfume mixture in a cosmetically acceptable vehicle. Slow release has also been achieved through pro-accords. These chemicals slowly break down releasing an odoriferous component as a degradation fragment. Menthol is the rnost frequent commercially delivered degradation constituent of pro-accords contained in personal cars compositions. Illustrative of this technology is U.S. Patent 6,100233 (Sivik et al.) employing a β-ketoester pro-accord which transforms to chemically release fragranced alcohols such as linalool, dihydromyrcenol and other alcohols. Steady release technologies have also been reported. Most prominent are a series of disclosures on enduring perfumes. See U.S. Patent 5,833,999; U.S. Patent 5,849,310 and U.S. Patent 6,086,903 all to Trinh et al. describing personal treatment compositions delivering an enduring perfume that provides a lasting olifactory sensation. Although technologies are known for delayed release and prolonged perfume generation, none has solved the problem of rapidly releasing a. fragrance onto human skin or hair. SUMMARY OF THE INVENTION A personal care composition is provided which includes: (i) from 0.000001 to 2% of a fragrance component selected from the group consisting of limonene, gamma terpinene, ethylene brassylate and mixtures thereof; (ii) from 0.05% to 30% by weight of a dihydroxypropylquaternary ammonium salt of structure AB, wherein A is a cationic charged component of the salt AB, B is an anionic charged component of the salt AB, and A has a single quaternized nitrogen atom, at least two hydroxy groups and a molecular weight no higher than 250; and (iii) a cosmetically acceptable canier. DETAILED DESCRIPTION OF THE INVENTION Now it has been found that fragrance components limonene, gamma terpinene and ethylene brassylate can have their volatility enhanced from a personal care composition through use of a scent boosting agent. This agent has been found to be dihydroxypropyl quaternary ammonium salts. By the term personal care composition is meant any product applied to a human body for improving appearance, cleansing, odor control or general aesthetics. Non-limiting examples of personal care compositions include leave-on skin lotions and creams, shampoos, conditioners, shower gels, toilet bars, antiperspirants, deodorants, dental products, shave creams, depilatories, lipsticks, foundations, mascara, sunless tanners and sunscreen lotions. An important material of the present invention is dihydroxypropyl quaternary ammonium salts of structure AB, wherein A is a cationic charged component of the salt AB, and B is an anionic charged component of the salt AB, A has one quatemized nitrogen atom, at least two hydroxyl groups and a molecular weight no higher than 250 but preferably no higher than 200, and optimally no higher than 170. Anionic charged component B may be organic or inorganic with proviso that the material is cosmetically acceptable. Typical inorganic anions are halides, sulfates, phosphates, nitrates and borates. Most preferred are the halides, especially chloride. Organic anionic counter ions include methosulfate, toluoyl sulfate, acetate, citrate, tartrate, lactate, gluconate, and benzenesulfonate. The number and charge of negatively charged component B will be sufficient to neutralize the positive charge of component A. A preferred embodiment of the quaternary ammonium salts is the dihydroxypropyl tri(C1-C3 alkyl or hydroxyalkyl) ammonium salts. These salts may be obtained in a variety of synthetic procedures, most particularly by hydrolysis of chlorohydroxypropyltri(C1-C3 alkyl or hydroxyalkyl) ammonium salts. Ordinarily the C1-C3 alkyl or hydroxyalkyl constituent on the quatemized ammonium group will be methyl, ethyl, n-propyl, isopropyl, hydroxyethyl, hydroxymethyl and mixtures thereof. Particularly preferred is a trimethyl ammonium group known through INCI nomenclature as a "trimonium" group. A most preferred species is 1,2-dihydroxypropyltrimonium chloride, wherein the C1-C3 alkyl is a methyl group. Amounts of the quaternary ammonium salts may range from 0.05 to 30%, preferably from 0.1 to 25%, more preferably from 5 to 20%, optimally from 10 to 15% by weight of the personal care composition. The fragrance components susceptible of a boost according to the present invention are limonene, gamma terpinene, ethylene brassylate and combinations thereof. Ethylene brassylate is particularly useful as a scent for masking malodor in compositions having essentially no other fragrance component mixtures. Amounts of each of these components may each range from 0.000001 to 2%, preferably from 0.00001 to 1%, more preferably from 0.0001 to 0.5%, and optimally from 0.001 to 0.1% by weight of the personal care composition. Compositions of this invention will also include a cosmetically acceptable carrier. Amounts of the carrier may range from 1 to 99.9%, preferably from 70 to 95%, optimally from 80 to 90% by weight of the personal care composition. Among the useful carriers are water, emollients, fatty acids, fatty alcohols, humectants, thickeners and combinations thereof. The carrier may be aqueous, anhydrous or an emulsion. Preferably the compositions are aqueous, especially water and oil emulsions of the W/O or O/W or triplex W/O/W variety. Water when present may be in amounts ranging from 5 to 95%, preferably from 20 to 70%, optimally from 35 to 60% by weight of the personal care composition. Emollient materials may serve as cosmetically acceptable carriers. These may be in the form of silicone oils, synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from 0.1 to 95%, preferably between 1 and 50% by weight of the personal care composition. Silicone oils may be divided into the volatile and non-volatile variety. The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms. Non-volatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially non-volatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from 5 x 10"6 to 0.1 m2/s at 25°C. Among the preferred non-volatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from 1 x 10"5 to 4 x 10"* m2/s at 25°C. Another class of nonvolatile silicones are emulsifying and non-emulsifying silicone elastomers. Representative of this category is DimethiconeA/inyl Dimethicone Crosspolymer available as Dow Coming 9040, General Electric SFE 839, and Shin-Etsu KSG-18. Silicone waxes such as Silwax WS-L (Dimethicone Copolyol Laurate) may also be useful. Among the ester emollients are: 1) Alkyl esters of saturated fatty acids having 10 to 24 carbon atoms. Examples thereof include behenyl neopentanoate, isononyl isonanonoate, isopropyl myristate and octyl stearate. 2) Ether-esters such as fatty acid esters of ethoxylated saturated fatty alcohols. 3) Polyhydric alcohol esters. Ethylene glycol mono- and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters. Particularly useful are pentaerythritol, trimethylolpropane and neopentyl glycol esters of C1-C30 alcohols. 4) Wax esters such as beeswax, spermaceti wax and tribehenin wax. 5) Sugar ester of fatty acids such as sucrose polybehenate and sucrose polycottonseedate. Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C11-C13 isoparaffins, and especially isohexadecane, available commercially as Permethyl 101A from Presperse Inc. Fatty acids having from 10 to 30 carbon atoms may also be suitable as cosmetically acceptable carriers. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, hydroxystearic and behenic acids. Fatty alcohols having from 10 to 30 carbon atoms are another useful category of cosmetically acceptable carrier. Illustrative of this category are stearyl alcohol, lauryl alcohol, myristyl alcohol and cetyl alcohol. Humectants of the polyhydric alcohol-type can be employed as cosmetically acceptable carriers. Typical polyhydric alcohols include glycerol, polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. The amount of humectant may range anywhere from 0.5 to 50%, preferably between 1 and 15% by weight of the personal care composition. Thickeners can be utilized as part of the cosmetically acceptable carrier of compositions according to the present invention. Typical thickeners include crosslinked acrylates (e.g. Carbopol 982®), hydrophobically-modified acrylates (e.g. Carbopol 1382®), cellulosic derivatives and natural gums. Among useful cellulosic derivatives are sodium carboxymethylcellulose, hydroxypropyl methocellulose, hydroxypropyl cellulose, hydroxyethyi cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenan, pectin and combinations of these gums. Inorganics may also be utilized as thickeners, particularly clays such as bentonites and hectorites, fumed silicas, and silicates such as magnesium aluminum silicate (Veegum®). Amounts of the thickener may range from 0.0001 to 10%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight of the personal care composition. Personal care compositions of the present invention may be in any form. These forms may include lotions, creams, roll-on formulations, sticks, mousses, aerosol and non-aerosol sprays and fabric (e.g. nonwoven textile)-applied formulations. Surfactants may also be present in compositions of the present invention. Total concentration of the surfactant when present may range from 0.1 to 40%, preferably from 1 to 20%, optimally from 1 to 5% by weight of the personal care composition. The surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic surfactants are those with a C10-C20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-C10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di- C8-C20 fatty acids; and polyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e.g. methyl gluconamides) are also suitable nonionic surfactants. Preferred anionic surfactants include soap, alkyl ether sulfates and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-C20 acyl isethionate, C8-C20 alkyl ether phosphates, C8-C20 sarcosinates and combinations thereof. Sunscreen actives may also be included in compositions of the present invention. Particularly preferred are such materials as ethylhexyl p-methoxycinnamate (available as Parsol MCX®), Avobenzene (available as Parsol 1789®), octylsalicylate (available as Dermablock OS®), tetraphthalylidene dicamphor sulfonic acid (available as Mexoryl SX®), benzophenone-4 and benzophenone-3 (Oxybenzone). Inorganic sunscreen actives may be employed such as microfine titanium dioxide, zinc oxide, polyethylene and various other polymers. By the term "microfine" is meant particles of average size ranging from 10 to 200 nm, preferably from 20 to 100 nm. Amounts of the sunscreen agents when present may generally range from 0.1 to 30%, preferably from 2 to 20%, optimally from 4 to 10% by weight of the personal care composition. Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms. Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the emulsion. Preservatives are preferably employed in amounts ranging from 0.01% to 2% by weight of the personal care composition. Compositions of the present invention may include vitamins. Illustrative vitamins are vitamin A (retinol), vitamin B2, vitamin B3 (niacinamide), vitamin B6, vitamin C, vitamin E and biotin. Derivatives of the vitamins may also be employed. For instance, vitamin C derivatives include ascorbyl tetraisopalmitate, magnesium ascorbyl phosphate and ascorbyl glycoside. Derivatives of vitamin E include tocopheryl acetate, tocopheryl palmitate and tocopheryl linoleate. DL-panthenol and derivatives may also be employed. A particularly suitable vitamin B6 derivative is pyridoxine palmitate. Flavanoids may also be useful, particularly glucosyl hesperidin, rutin, and soy isofiavones (including genistein, daidzein, equol, and their glucosyl derivatives) and mixtures thereof. Total amount of vitamins or flavonoids when present may range from 0.0001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight of the personal care composition. Another type of useful substance can be that of an enzyme such as oxidases, proteases, lipases and combinations. Particularly preferred is superoxide dismutase, commercially available as Biocell SOD from the Brooks Company, USA. Skin lightening compounds may be included in the compositions of the invention. Illustrative substances are placental extract, lactic acid, niacinamide, arbutin, kojic acid, ferulic acid, resorcinol and derivatives including 4-substituted resorcinols and combinations thereof. Amounts of these agents may range from 0.1 to 10%, preferably from 0.5 to 2% by weight of the personal care composition. Desquamation promoters may be present. Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids. The term "acid" is meant to include not only the free acid but also salts and C1-C30 alkyl or aryl esters thereof and lactones generated from removal of water to form cyclic or linear lactone structures. Representative acids are glycolic, lactic and malic acids. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from 0.01 to 15% by weight of the personal care composition. A variety of herbal extracts may optionally be included in compositions of this invention. Illustrative are pomegranate, white birch (Betula Alba), green tea, chamomile, licorice and extract combinations thereof. The extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents. Also included may be such materials as lipoic acid, kinetin, retinoxytrimethylsilane (available from Clariant Corp. under the Silcare 1M-75 trademark), dehydroepiandrosterone (DHEA) and combinations thereof. Ceramides (including Ceramide 1, Ceramide 3, Ceramide 3B, Ceramide 6 and Ceramide 7) as well as pseudoceramides may also be utilized for many compositions of the present invention but may also be excluded. Amounts of these materials may range from 0.000001 to 10%, preferably from 0.0001 to 1 % by weight of the personal care composition. Colorants, opacifiers and abrasives may also be included in compositions of the present invention. Each of these substances may range from 0.05 to 5%, preferably between 0.1 and 3% by weight of the personal care composition. The compositions of the present invention can also be, optionally, incorporated into a water insoluble substrate for application to the skin such as in the form of a treated wipe. All documents referred to herein, including all patents, patent applications, and printed publications, are hereby incorporated by reference in their entirety in this disclosure. The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated. EXAMPLE 1 A representative personal care composition of the present invention in the form of a cosmetic lotion is outlined under table I. TABLE I INGREDIENT WEIGHT % PHASE A Water Balance Disodium EDTA 0.05 Methyl paraben 0.15 Magnesium aluminum silicate 0.60 Triethanolamine 1.20 Dihydroxypropyl trimonium chloride 1.00 PHASE B Xanthan gum 0.20 Natrosol®250HHR (ethyl cellulose) 0.50 Butylene glycol 3.00 Glycerin 2.00 PHASE C Sodium stearoyl lactylate 0.10 Glycerol monostearate 1.50 Stearyl alcohol 1.50 Isostearyl palmitate 3.00 Silicone fluid 1.00 Cholesterol 0.25 Sorbitan stearate 1.00 Butylated hydroxy toluene 0.05 Vitamin E acetate 0.01 PEG-100 stearate 2.00 Stearic acid 3.00 Propyl paraben 0.10 Parsol MCX® 2.00 Caprylic/Capric triglyceride 0.50 Hydroxycaprylic acid 0.01 C12-15Alkyloctanoate 3.00 PHASE D Vitamin A palmitate 0.10 Bisabolol 0.01 Vitamin A acetate 0.01 Fragrance (20% limonene and 3% gamma terpinene) 0.03 Retinol 50C 0.02 Conjugated linoleic acid 0.50 EXAMPLE 2 A water-in-oil topical liquid make-up foundation according to invention is described in yable II below. TABLE II INGREDIENT WEIGHT % PHASEA Cydomethicone 9.25 Oleyl oleate 2.00 Dimethicone copolyol 20.00 PHASE B Talc 3.38 Pigment (iron oxides) 10.51 Spheron L-1500 (silica) 0.50 PHASEC Synthetic wax Durachem 0602 0.10 Arachidyl behenate 0.30 PHASE D Cydomethicone 1.00 Trihydroxystearin 0.30 PHASE E Laureth-7 0.50 Propyl paraben 0.25 PHASE F Fragrance (50% limonene and 10% gamma terpinene) 0.05 PHASE G Water balance Dihydroxypropyl trimonium chloride 3.00 Methyl paraben 0.12 Propylene glycol 8.00 Niacinamide 4.00 Glycerin 3.00 Sodium chloride 2.00 Sodium dehydroacetate 0.30 EXAMPLE 3 A relatively anhydrous composition incorporating the quat salt and a fragrance mask formed substantially only from ethylene brassylate is reported in table III. TABLE III INGREDIENT WEIGHT % Cyclomethicone 60.65 Glycerin 15.00 Dimethicone 10.10 Squalane 6.00 Dihydroxypropyltrimonium chloride 5.00 Isostearic acid 1.90 Ethylene brassylate 0.90 Retjnyl palmitate 0.25 Ceramide 6 0.10 Tocopherol 0.10 EXAMPLE 4 An aerosol packaged foaming cleanser with a quat salt and limonene as a major component of the fragrance is outlined in table IV. TABLE IV INGREDIENT WEIGHT % Sunflower seed oil 10.00 Glycerin 10.00 Maleated soybean oil 5.00 Silicone urethane 1.00 Polyglycero-4 oleate 1.00 Sodium C14-16 olefin sulfonate 15.00 Sodium lauryl ether sulphate (25% active) 15.00 Cocoamidopropylbetaine 15.00 DC 1784® (silicone emulsion 50%) 5.00 Polyquaternium-11 1.00 Dihydroxypropyltrimonium chloride 1.00 Fragrance (20% limonene) 1.00 Water Balance EXAMPLE 5 A disposable, single use personal care towelette product is described according to the present invention. A 70/30 polyester/rayon non-woven towelette is prepared with a weight of 1.8 grams and dimensions of 15 cm by 20 cm. Onto this towelette is impregnated 1.0 grams of a composition including a quaternary ammonium salt and a fragrance having 20% limonene and 20% gamma terpinene as outlined in table V below. TABLE V INGREDIENT WEIGHT % Dihydroxypropyltrimonium chloride 4.00 Glycerin 12.00 Hexylene glycol 2.00 Disodium capryl amphodiacetate 1.00 Gluconolactone 0.90 Silicone microemulsion 0.85 Witch Hazel 0.50 PEG40 Hydrogenated castor oil 0.50 Fragrance (20% limonene and 20% gamma terpinene) 0.20 Vitamin E acetate 0.001 Water Balance EXAMPLE 6 A toilet bar illustrative of the present invention is outlined under table VI. TABLE VI INGREDIENT WEIGHT % Sodium soap (85/15 tallow/coconut) 77.77 Dihydroxypropyltrimonium chloride 3.50 Dimethicone 2.00 Sodium chloride 0.77 Titanium dioxide 0.40 Ethylene brassylate 1.50 Disodium EDTA 0.02 Sodium etidronate 0.02 Fluorescer 0.024 Water Balance EXAMPLE 7 A shampoo composition useful in the context of the present invention is described in table VII below. TABLE VII Ingredient Weight % Ammonium laureth sulfate 12.00 Ammonium lauryl sulfate 2.00 Gocoamidopropyl betaine 2.00 Sodium lauroamphoacetate 2.00 Glycerin 12.00 Dihydroxypropyltrimonium chloride 5.50 Ethylene glycol distearate 1.50 Cocomonoethanolamide 0.80 Cetyl alcohol 0.60 Polyquatemium-10 0.50 Dimethicone 1.00 Zinc pyridinethione 1.00 Sodium citrate 0.40 Citric acid 0.39 Sodium xylene sulfonate 1.00 Fragrance (10% limonene) 0.40 Sodium benzoate 0.25 Kathon CG® 0.0008 Benzyl alcohol 0.0225 Water Balance EXAMPLE 8 This example illustrates an antiperspirant/deodorant formula incorporating the quaternary ammonium salts and ethylene brassylate fragrance mask component according to the present invention. TABLE VIII Ingredient Weight % Cyclopentasiloxane 39 Dimethicone 20 Aluminum zirconium trichlorohydrex glycinate 15 Dihydroxypropyltrimonium chloride 5.0 Cig-C36 Acid triglyceride 5.0 Microcrystalline wax 3.0 Glycerin 8.0 Silica 2.5 Dimethicone crosspolymer 1.0 Ethylene brassylate 0.5 Disodium EDTA 0.4 Butylated hydroxytoluene 0.3 Citric acid 0.3 EXAMPLE 9 A series of experiments were conducted to evaluate release and prolonged scent generation of typical components of a perfume mixture. Samples were prepared at room temperature (23° C) by mixing 10% by weight of the sample of scent boosting agent (dihydroxypropyl quaternary ammonium salt) in water along with 0.05% of weight of the sample Deep Moisture perfume oil. This oil is a mixture of components including but not limited to limonene, dihydromyrcenol, benzyl acetate, gamma terpinene, linalool, pinene, isomethyl ionone, and others. Samples were analyzed by gas chromatography (GC) analysis of headspace gases. In this procedure, the equipment utilized was a solid phase microextraction (SPME) system employing an Agilent gas chromatography (GC) 6890 / mass spectrometry (MS) 5973 / flame ionization detector (FID). This equipment measured relative perfume compound abundance in the headspace over the fragrance/boosting agent/water mixture, as well as over the fragrance/water mixture. One gram of fragrance/boosting agent/water mixture was prepared in 20 ml GC headspace sampling vials sealed with caps having septums (from Gerstel, Inc.) and held at room temperature (23°C). The GC column was a HP-5MS column from Agilent (inner diameter 0.25 mm, length 30 m, stationary phase thickness 0.25um). The GC conditions were as follows: Injector in splitless mode with helium gas as carrier gas. Injection port was heated to 250°C, purge flow to split vent 50ml/min at zero minutes. Column was in constant flow mode with 1.3 ml/min flow rate. Oven temperature ramp: hold at 75°C for 2 minutes, then increase oven temperature at a rate of 6°C/min to 100°C, 1.5°C/min to 150°C, 3°C/,min to 190°C, 30°C/min to 300°C and hold for 2 minutes. MS conditions were: solvent delay for 0.5 minutes, scan starting from low mass 35 to high mass 300. Autosamplers conditions were: No incubation (all experiments done in room temperature). SPME fibre was inserted into the sample headspace for a 5 minute extraction and then injected to the injector for a 15 minute desorption. In the situation of ethylene brassylate, this material was charged at 0.01 g into a 20 g solution of boosting agent/water. The added ethylene brassylate was above the solubility level of this material in the boosting agent/water solution. In the GC headspace analysis for ethylene brassylate, MS conditions were: solvent delay for 0.5 min., SIM mode (selective ion) for 99 and 98 ions. All other conditions were identical to that noted in the previous paragraph. Results of the experiments are reported in table IX below. TABLE IX Fragrance Component Water 10% GQ 1-Butanol, 3-methyl acetate 1.00 1.09 2-Buten-1-ol, 3-methyl acetate 1.00 1.04 Beta pinene 1.00 1.72 Hexyl acetate 1.00 1.41 Limonene 1.00 2.72 2,6-Dimethyl hept-5-en-1-al 1.00 0.38 Gamma terpinene 1.00 2.15 Dihydromyrcenol 1.00 1.00 2,4 DimethyK3-cyclohexene-1 -carbaldehyde 1.00 1.06 Linalool 1.00 0.97 Benzyl acetate 1.00 0.86 Allyl heptoate 1.00 1.23 2-Tertiobutylcyclohexyl acetate-2 1.00 1.16 Alpha isomethyl ionone 1.00 0.86 Lily aldehyde 1.00 0.97 Ethylene brassylate 1.00 2.64 GQ = dihydroxypropyl trimonium chloride Evident from the results in table IX is that certain fragrance ingredients are particularly boosted into the headspace by the presence of the quaternary ammonium salt. These ingredients are limonene, gamma terpinene and ethylene brassylate. CLAIMS 1. A personal care composition comprising: (i) from 0.000001 to 2% of a fragrance component selected from the group consisting of limonene, gamma terpinene, ethylene brassylate and mixtures thereof; (ii) from 0.05% to 30% by weight of a dihydroxypropyl quaternary ammonium salt of structure AB, wherein A is a cationic charged component of the salt AB, B is an anionic charged component of the salt AB, and A has a single quaternized nitrogen atom, at least two hydroxy groups and a molecular weight no higher than 250; and (iii) a cosmetically acceptable carrier. 2. A composition according to claim 1 wherein the quaternary ammonium salt is a dihydroxypropyltri(C1-C3 alkyl) ammonium salt. 3. A composition according to claim 2 wherein the salt is dihydroxypropyltrimonium chloride. 4. A composition according to any one of the preceding claims which is selected from the group consisting of leave-on skin lotions and creams, shampoos, hair conditioners, shower gels, toilette bars, antiperspirants, deodorants, dental products, shave creams, depilatories, lipsticks, foundations, mascara, sunless tanner and sunscreen lotions. 5. A composition according to any one of the preceding claims wherein the fragrance component is limonene. 6. A composition according to any one of claims 1 to 4 wherein the fragrance component is gamma terpinene. 7. A composition according to any one of claims 1 to 4 wherein the fragrance component is ethylene brassylate. 8. A composition according to any one of claim 1, claim 2 or claim 4 wherein the fragrance component is limonene and the quaternary ammonium salt is dihydroxypropyltrimonium chloride. 9. A composition according to any one of claim 1, claim 2 or claim 4 wherein the fragrance component is ethylene brassylate and the quaternary ammonium salt is dihydroxypropyltrimonium chloride.

Documents:

1817-MUMNP-2009 1-CORRESPONDENCE(15-8-2009).pdf

1817-MUMNP-2009-ANNEXURE TO FORM 3(24-2-2012).pdf

1817-MUMNP-2009-ASSIGNMENT(7-10-2009).pdf

1817-MUMNP-2009-CLAIMS(1-10-2009).pdf

1817-MUMNP-2009-CLAIMS(AMENDED)-(24-2-2012).pdf

1817-mumnp-2009-claims.doc

1817-mumnp-2009-claims.pdf

1817-MUMNP-2009-CORRESPONDENCE(05-05-2010).pdf

1817-MUMNP-2009-CORRESPONDENCE(11-1-2013).pdf

1817-MUMNP-2009-CORRESPONDENCE(14-9-2009).pdf

1817-MUMNP-2009-CORRESPONDENCE(15-10-2009).pdf

1817-MUMNP-2009-CORRESPONDENCE(15-10-2012).pdf

1817-MUMNP-2009-CORRESPONDENCE(7-10-2009).pdf

1817-MUMNP-2009-CORRESPONDENCE(IPO)-(17-12-2009).pdf

1817-mumnp-2009-correspondence.pdf

1817-MUMNP-2009-DESCRIPTION(COMPLETE)-(1-10-2009).pdf

1817-mumnp-2009-description(complete).doc

1817-mumnp-2009-description(complete).pdf

1817-MUMNP-2009-EP DOCUMENT(24-2-2012).pdf

1817-mumnp-2009-form 1.pdf

1817-MUMNP-2009-FORM 13(9-2-2012).pdf

1817-MUMNP-2009-FORM 18(15-8-2009).pdf

1817-MUMNP-2009-FORM 2(COMPLETE)-(1-10-2009).pdf

1817-MUMNP-2009-FORM 2(TITLE PAGE)-(1-10-2009).pdf

1817-mumnp-2009-form 2(title page).pdf

1817-mumnp-2009-form 2.doc

1817-mumnp-2009-form 2.pdf

1817-MUMNP-2009-FORM 3(1-10-2009).pdf

1817-MUMNP-2009-FORM 3(12-8-2011).pdf

1817-MUMNP-2009-FORM 3(15-2-2011).pdf

1817-MUMNP-2009-FORM 3(15-2-2012).pdf

1817-MUMNP-2009-FORM 3(23-1-2013).pdf

1817-MUMNP-2009-FORM 3(24-2-2010).pdf

1817-MUMNP-2009-FORM 3(4-8-2010).pdf

1817-MUMNP-2009-FORM 3(8-8-2012).pdf

1817-mumnp-2009-form 3.pdf

1817-mumnp-2009-form 5.pdf

1817-MUMNP-2009-FORM 9(15-10-2009).pdf

1817-MUMNP-2009-GENERAL POWER OF ATTORNEY(14-10-2009).pdf

1817-mumnp-2009-pct-isa-210.pdf

1817-mumnp-2009-pct-isa-237.pdf

1817-MUMNP-2009-REPLY TO EXAMINATION REPORT(24-2-2012).pdf

1817-MUMNP-2009-US DOCUMENT(24-2-2012).pdf

1817-mumnp-2009-wo international publication report a1.pdf